Literature DB >> 21209079

Generation of a new form of human PrP(Sc) in vitro by interspecies transmission from cervid prions.

Marcelo A Barria1, Glenn C Telling, Pierluigi Gambetti, James A Mastrianni, Claudio Soto.   

Abstract

Prion diseases are infectious neurodegenerative disorders that affect humans and animals and that result from the conversion of normal prion protein (PrP(C)) into the misfolded prion protein (PrP(Sc)). Chronic wasting disease (CWD) is a prion disorder of increasing prevalence within the United States that affects a large population of wild and captive deer and elk. Determining the risk of transmission of CWD to humans is of utmost importance, considering that people can be infected by animal prions, resulting in new fatal diseases. To study the possibility that human PrP(C) can be converted into the misfolded form by CWD PrP(Sc), we performed experiments using the protein misfolding cyclic amplification technique, which mimics in vitro the process of prion replication. Our results show that cervid PrP(Sc) can induce the conversion of human PrP(C) but only after the CWD prion strain has been stabilized by successive passages in vitro or in vivo. Interestingly, the newly generated human PrP(Sc) exhibits a distinct biochemical pattern that differs from that of any of the currently known forms of human PrP(Sc). Our results also have profound implications for understanding the mechanisms of the prion species barrier and indicate that the transmission barrier is a dynamic process that depends on the strain and moreover the degree of adaptation of the strain. If our findings are corroborated by infectivity assays, they will imply that CWD prions have the potential to infect humans and that this ability progressively increases with CWD spreading.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21209079      PMCID: PMC3045004          DOI: 10.1074/jbc.M110.198465

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding.

Authors:  G P Saborio; B Permanne; C Soto
Journal:  Nature       Date:  2001-06-14       Impact factor: 49.962

2.  Survival of scrapie virus after 3 years' interment.

Authors:  P Brown; D C Gajdusek
Journal:  Lancet       Date:  1991-02-02       Impact factor: 79.321

3.  Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins.

Authors:  R J Kascsak; R Rubenstein; P A Merz; M Tonna-DeMasi; R Fersko; R I Carp; H M Wisniewski; H Diringer
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

4.  Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD.

Authors:  J Collinge; K C Sidle; J Meads; J Ironside; A F Hill
Journal:  Nature       Date:  1996-10-24       Impact factor: 49.962

5.  Subclinical scrapie infection in a resistant species: persistence, replication, and adaptation of infectivity during four passages.

Authors:  Richard Race; Kimberly Meade-White; Anne Raines; Gregory J Raymond; Byron Caughey; Bruce Chesebro
Journal:  J Infect Dis       Date:  2002-12-01       Impact factor: 5.226

6.  Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein.

Authors:  G C Telling; M Scott; J Mastrianni; R Gabizon; M Torchia; F E Cohen; S J DeArmond; S B Prusiner
Journal:  Cell       Date:  1995-10-06       Impact factor: 41.582

Review 7.  Chronic wasting disease of cervids.

Authors:  M W Miller; E S Williams
Journal:  Curr Top Microbiol Immunol       Date:  2004       Impact factor: 4.291

Review 8.  Bovine spongiform encephalopathy, chronic wasting disease, scrapie, and the threat to humans from prion disease epizootics.

Authors:  Patrick J Bosque
Journal:  Curr Neurol Neurosci Rep       Date:  2002-11       Impact factor: 5.081

9.  Transmission of prions from mule deer and elk with chronic wasting disease to transgenic mice expressing cervid PrP.

Authors:  Shawn R Browning; Gary L Mason; Tanya Seward; Mike Green; Gwyneth A J Eliason; Candace Mathiason; Michael W Miller; Elizabeth S Williams; Ed Hoover; Glenn C Telling
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

10.  Chronic wasting disease prions are not transmissible to transgenic mice overexpressing human prion protein.

Authors:  Malin K Sandberg; Huda Al-Doujaily; Christina J Sigurdson; Markus Glatzel; Catherine O'Malley; Caroline Powell; Emmanuel A Asante; Jacqueline M Linehan; Sebastian Brandner; Jonathan D F Wadsworth; John Collinge
Journal:  J Gen Virol       Date:  2010-07-07       Impact factor: 3.891

View more
  53 in total

1.  In vitro generation of high-titer prions.

Authors:  Ronald A Shikiya; Jason C Bartz
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

2.  PrP(Sc)-specific antibodies do not induce prion disease or misfolding of PrP(C) in highly susceptible Tga20 mice.

Authors:  Pekka Määttänen; Ryan Taschuk; Li Ross; Kristen Marciniuk; Lisa Bertram; Andrew Potter; Neil R Cashman; Scott Napper
Journal:  Prion       Date:  2013-10-08       Impact factor: 3.931

Review 3.  Molecular Mechanisms of Chronic Wasting Disease Prion Propagation.

Authors:  Julie A Moreno; Glenn C Telling
Journal:  Cold Spring Harb Perspect Med       Date:  2018-06-01       Impact factor: 6.915

4.  Lesion profiling and subcellular prion localization of cervid chronic wasting disease in domestic cats.

Authors:  D M Seelig; A V Nalls; M Flasik; V Frank; S Eaton; C K Mathiason; E A Hoover
Journal:  Vet Pathol       Date:  2014-02-27       Impact factor: 2.221

5.  Strain conformation controls the specificity of cross-species prion transmission in the yeast model.

Authors:  Anastasia V Grizel; Aleksandr A Rubel; Yury O Chernoff
Journal:  Prion       Date:  2016-07-03       Impact factor: 3.931

Review 6.  Evaluating the Species Barrier.

Authors:  Jean C Manson; Abigail B Diack
Journal:  Food Saf (Tokyo)       Date:  2016-12-07

Review 7.  Implications of peptide assemblies in amyloid diseases.

Authors:  Pu Chun Ke; Marc-Antonie Sani; Feng Ding; Aleksandr Kakinen; Ibrahim Javed; Frances Separovic; Thomas P Davis; Raffaele Mezzenga
Journal:  Chem Soc Rev       Date:  2017-10-30       Impact factor: 54.564

Review 8.  Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.

Authors:  Julie A Moreno; Glenn C Telling
Journal:  Methods Mol Biol       Date:  2017

9.  Prion formation, but not clearance, is supported by protein misfolding cyclic amplification.

Authors:  Ronald A Shikiya; Thomas E Eckland; Alan J Young; Jason C Bartz
Journal:  Prion       Date:  2014       Impact factor: 3.931

10.  Protein misfolding cyclic amplification of infectious prions.

Authors:  Rodrigo Morales; Claudia Duran-Aniotz; Rodrigo Diaz-Espinoza; Manuel V Camacho; Claudio Soto
Journal:  Nat Protoc       Date:  2012-06-28       Impact factor: 13.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.